VKTX: Viking Therapeutics Inc

27.51 USD 0.47 (1.68%)

Sector: Healthcare Base: US Dollar Profit currency: US Dollar

VKTX exchange rate has changed by -1.68% for today. During the day, the instrument was traded at a low of 27.10 and at a high of 28.24.

Follow Viking Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.

Full Screen Chart

VKTX News

The Motley Fool 07:45 Better Growth Buy: Eli Lilly vs. Viking Therapeutics
The Motley Fool 08:30 Why I Think Viking Therapeutics Is an Asymmetric Growth Opportunity
Seeking Alpha 19:05 Viking: I'm Bullish On Oral/Injectable GLP-1 Obesity Data Catalysts (NASDAQ:VKTX)
The Motley Fool 11:00 2 Beaten-Down Stocks With Massive Upside Potential
The Motley Fool 10:30 10 Incredible Growth Stocks Poised for Long-Term Gains
The Motley Fool 11:15 Got $200? 2 Biotech Stocks to Buy and Hold Forever
Investor's Business Daily 20:05 Can Protagonist Take On Eli Lilly's Next-Generation Obesity Treatment?
The Motley Fool 17:59 Why This Weight Loss Drug Company's Stock Surged Today
Investing 11:30 Viking Therapeutics stock maintains buy rating as phase 3 trials begin
The Motley Fool 09:15 3 Growth Stocks I'm Loading Up On
Investing 19:00 BTIG reiterates buy rating on Viking Therapeutics stock amid obesity trials
Investor's Business Daily 18:07 Why Viking Therapeutics, 67% Off Its Recent Highs, Could Still Have An Edge In Obesity
Benzinga 17:01 What's Going On With Viking Therapeutics Stock On Wednesday? - Viking Therapeutics (NASDAQ:VKTX)
Investing 16:54 Viking Therapeutics stock rating reiterated at Outperform by Leerink
Investing 15:03 H.C. Wainwright reiterates buy rating on Viking Therapeutic stock
Investing 11:14 Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735
The Motley Fool 11:10 My 5 Favorite Dirt Cheap Stocks to Buy Right Now
Investor's Business Daily 18:30 Amgen Hammered As 'Tough' Obesity Meeting Reminds It It's Not The Incumbent
Investing 18:01 Tesla, Regencell lead market cap stock movers this Monday
The Motley Fool 22:10 2 Biotech Stocks to Buy Before They Soar 84% and 240%, According to Certain Wall Street Analysts
The Motley Fool 13:53 Missed Out on Eli Lilly's 480% Gains Over the Past 5 Years? These GLP-1 Stocks Still Have Plenty of Upside.
TipRanks 04:31 Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200% - TipRanks.com
The Motley Fool 11:30 Are These 2 High-Flying Growth Stocks Still Worth Buying After Recent Pullbacks?
Seeking Alpha 14:03 Promising Results Of Amylin Analogs In Obesity: Metsera Case Review (NASDAQ:MTSR)

Daily Range

27.10 28.24

Year Range

18.92 81.04

Previous Close: 28.19
Open: 27.98

Bid: 27.51
Ask: 27.81

Low: 27.10
High: 28.24

Volume: 6.123 K

Daily Change: -1.68%
Month Change: 4.40%

6 Months Change: -12.39%
Year Change: -51.57%

08 July, Tuesday